IMPROVED YIELDS OF FACTOR-VIII FROM HEPARINIZED PLASMA

被引:54
作者
ROCK, GA [1 ]
CRUICKSHANK, WH [1 ]
TACKABERRY, ES [1 ]
PALMER, DS [1 ]
机构
[1] UNIV OTTAWA,FAC MED,OTTAWA K1N 9A9,ONTARIO,CANADA
关键词
D O I
10.1111/j.1423-0410.1979.tb04437.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. The Factor VIII procoagulant activity in plasma, cryoprecipitate, and their polyethylene glycol (PEG) precipitates is markedly increased if blood is collected into heparin rather than into citrate phosphate dextrose (CPD). There is a 34% increase in the initial level of the Factor VIII activity in the heparinized plasma with 78% of this initial activity (184 U) recovered in the cryoprecipitate. As well, the stability of the Factor VIII activity is improved: after 24 h of incubation at 22°C, 99% of the initial activity is retained in heparinized plasma whereas only 64% remains in CPD plasma. The cryoprecipitate prepared from heparinized plasma is equally stable after 24 h. The PEG concentrate prepared from the cryoprecipitate of heparinized plasma is increased to 128 U compared to only 54 U from CPD plasma. Relative recoveries were 531 U/l for heparinized plasma versus 215 U/l for CPD plasma. This represents a 147% increase in yield. © 1979 Blackwell Publishing Ltd
引用
收藏
页码:294 / 300
页数:7
相关论文
共 16 条
[1]   COMPARISON OF QUICK AND SLOW THAW METHODS OF PRODUCING CRYOPRECIPITATE ANTIHAEMOPHILIC FACTOR FROM FRESH AND 24-HOUR-OLD BLOOD [J].
BLOOM, AL ;
GIDDINGS, JC ;
BEVAN, B ;
LETTON, M ;
DRUMMOND, RJ .
JOURNAL OF CLINICAL PATHOLOGY, 1969, 22 (04) :447-&
[2]  
BRINKHOUS KM, 1968, JAMA-J AM MED ASSOC, V205, P67
[3]   INFLUENCE OF DONOR CHARACTERISTICS AND PREPARATION METHODS ON POTENCY OF HUMAN CRYOPRECIPITATE [J].
BURKA, ER ;
PUFFER, T ;
MARTINEZ, J .
TRANSFUSION, 1975, 15 (04) :323-328
[4]  
JOHNSON AJ, 1966, 11TH C INT SOC BLOOD, P1109
[5]   METHODS FOR PRODUCTION OF CLINICALLY EFFECTIVE INTERMEDIATE-PURITY AND HIGH-PURITY FACTOR-VIII CONCENTRATES [J].
NEWMAN, J ;
JOHNSON, AJ ;
KARPATKIN, MH ;
PUSZKIN, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 21 (01) :1-+
[6]   EFFECT OF SEVERAL VARIABLES ON CRYOPRECIPITATED FACTOR 8 (AHG) CONCENTRATES [J].
POOL, JG .
TRANSFUSION, 1967, 7 (03) :165-&
[7]   PRODUCTION OF HIGH-POTENCY CONCENTRATES OF ANTIHEMOPHILIC GLOBULIN IN A CLOSED-BAG SYSTEM - ASSAY IN VITRO AND IN VIVO [J].
POOL, JG ;
SHANNON, AE .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (27) :1443-&
[8]   CRYOPRECIPITATE QUALITY AND SUPPLY [J].
POOL, JG .
TRANSFUSION, 1975, 15 (04) :305-306
[9]   IMMUNOLOGICAL STUDIES OF ANTIHEMOPHILIC FACTOR (AHF, FACTOR-VIII) .5. IMMUNOLOGICAL PROPERTIES OF AHF SUBUNITS PRODUCED BY SALT DISSOCIATION [J].
RICK, ME ;
HOYER, LW .
BLOOD, 1973, 42 (05) :737-747
[10]   PRESENCE OF HIGH AND LOW-MOLECULAR WEIGHT FORMS OF FACTOR-VIII IN HEPARINIZED PLASMA [J].
ROCK, GA ;
PALMER, DS ;
TACKABERRY, ES ;
CRUICKSHANK, WH .
THROMBOSIS RESEARCH, 1978, 13 (01) :85-96